Discussion about this post

User's avatar
IGP Paradox's avatar

Great Read! By focusing on concentrate production and brand equity while outsourcing the heavy lifting of bottling and distribution, the company maintains high margins and a superior Return on Invested Capital (ROIC). It’s a classic lesson in how a global franchise can scale without the drag of massive physical infrastructure.

As consumer preferences shift toward health-conscious options and the "anti-sugar" regulatory environment intensifies, how does the company’s current acquisition strategy for "emerging brands" compare to its historical organic growth, and can these new categories ever match the fat margins of the core concentrate business?

No posts

Ready for more?